Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid

Endocrine Journal

Volumn 56, Issue 2, 2009, Pages 177-192

  Ito, Yasuhiro ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

Papillary carcinoma; Prognosis; Surgical treatment

Indexed keywords

ASPIRATION BIOPSY; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DISTANT METASTASIS; HIGH RISK POPULATION; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL PRACTICE; NECK DISSECTION; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PREVALENCE; PROGNOSIS; RACE DIFFERENCE; RADIODIAGNOSIS; REVIEW; RISK ASSESSMENT; SUBTOTAL THYROIDECTOMY; SURGICAL TECHNIQUE; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA, PAPILLARY; HUMANS; JAPAN; LYMPHATIC METASTASIS; PROGNOSIS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 66849089759     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K08E-166     Document Type: Review

References (113)

1. Correa P, Chen VW (1995) Endocrine gland cancer. Cancer 75: 338.
2. Parkin DM, Whelan SL, Ferlay J (2002) Cancer incidence in five continents. Vol. VIII Lyon: IARC Scientific.
3. Ezaki H, Ebihara S, Fujimoto Y, Iida F, Ito K, Kuma K, Izuo M, Makiuchi M, Oyamada H, Matoba N (1992) Analysis of thyroid carcinoma based on material registered in Japan during 1977-1986 with special reference to predominance of papillary type. Cancer 70: 808-814.
4. Ito Y, Amino N, Yokozawa T, Ota H, Ohshita M, Murata N, Morita S, Kobayashi K, Miyauchi A (2007) Ultrasonographic evaluation of thyroid nodules in 900 patients: comparison among ultrasonographic, cytolog- ical, and histological findings. Thyroid 17: 1269-1276.
5. Shimura H, Haraguchi K, Hiejima Y, Fukunari N, Fujimoto Y, Katagiri M, Kkoyanagi N, Kurita T, Miyakawa M, Miyamoto Y, Suzuki N, Suzuki S, Kanbe M, Kato Y, Murakami T, Tohno E, Tsunoda-Shimizu H, Yamada K, Ueno E, Kobayashi K, Kobayashi T, Yokozawa T, Kitaoka M (2005) Distinct diagnostic criteria for ultrasonographic examination of papillary thyroid carcinoma: a multicenter study. Thyroid 15: 251-258.
6. Yokozawa T, Miyauchi A, Kuma K, Sugawara M(1995) Accurate and simple method of diagnosing thyroid nodules the modified technique of ultrasound-guided fine needle aspiration biopsy. Thyroid 5: 141-145.
7. Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA (1990) Anaplastic carcinoma of the thyroid: a clinicopathologic study of 121 cases. Cancer 66: 321-330.
8. Tan RK, Finley RK, III, Driscoll D, Bakamjan V, Hicks WL Jr., Shedd DP (1995) Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck 17: 41-47.
9. Harach HR, Franssila KO, Wasenius VM (1985) Occult papillary carcinoma of the thyroid: A "normal" finding in Finland. Cancer 56: 531-538.
10. Fukunaga FH, Yatani R (1975) Geographic pathology of occult thyroid carcinomas. Cancer 36: 1095-1099.
11. Samson RJ (1977) Prevalence and significance of occult thyroid cancer. In: DeGroot LJ, ed. Radiation- associated thyroid carcinoma. New York, Grune & Stratton 137-153.
12. Nishiyama RH, Ludwig GK, Thompson NW (1977) The prevalence of small papillary thyroid carcinomas in 100 consecutive necropsies in an American population. In:DeGroot LJ, ed. Radiation-associated thyroid carcinoma. New York, Grune & Stratton 123-135.
13. Thorvaldsson SE, Tulinius H, Bjornsson J, Bjarnason O (1992) Latent thyroid carcinoma in Iceland at autopsy. Pathol Res Pract 188: 747-750.
14. Lang W, Borrusch G, Bauer L (1988) Occult carcinomas of the thyroid. Am J Clin Pathol 90: 72-76.
15. Yamamoto Y, Toshiharu M, Izumi K, Otsuka H (1990) Occult papillary carcinoma of the thyroid. Cancer 65: 1173-1179.
16. Takebe K, Date M, Yamamoto Y, Ogino T, Takeuchi Y (1994) Mass screening for thyroid cancer with ultrasonography. Karkinos 7: 309-317. (in Japanese)
17. Takebe K, Date M, Yamamoto Y, Ogino T (1996) The detection of minimal thyroid cancer in mass screening with ultrasonography. Geka 58: 651-654. (in Japanese)
18. Sampson RJ, Key CR (1970) Smallest forms of papillary carcinoma of the thyroid. Arch Pathl 91: 334-339.
19. Iida F, Sugenoya A, Muramatsu A (1991) Clinical and pathologic properties of small differentiated carcinomas of the thyroid gland. World J Surg 15: 511-515.
20. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ (1992) Papillary thyroid microcarcinoma: A study of 535 cases observed in a 50-year period. Surgery 112: 1139-1147.
21. Rodriguez JM, Moreno A, Paririla P, Sola J, Soria T, Tebar FJ, Aranda F (1997) Papillary thyroid micro- carcinoma: clinical study and prognosis. Eur J Surg 163: 255-259.
22. Lin KD, Lin JD, Huang MJ, Huang HS, Jeng LB, Chao C, Ho YS (1997) Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis. Int Surg 82: 378-381.
23. Rassael H, Thompson LDR, Heffess CS (1998) A ationale for conservative management of microscopic papillary carcinoma of the thyroid gland: a clinico- pathological correlation of 90 cases. Eur Arch Otorhi- nolaryngol 255: 462-467.
24. Sugitani I, Fujimoto Y (1999) Symptomatic versus asymptomatic papillary thyroid microcarcinoma: A retrospective analysis of surgical outcome and prognostic factors. Endocrine J 46: 209-216.
25. Falvo L, D'Ercole C, Sorrenti S, D'Andrea V, Catania , Berni A, Grillli P, De Antoni E (2003) Papillary icrocarcinoma of the thyroid gland: Analysis of prognostic factors including histological subtype. Eur J Surg 588: 28-32.
26. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama , Mimura T, Ito K, Takami H, Takanishi Y (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237: 399-407.
27. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH (2003) Papillary microcarcinoma of the thyroid: Prognostic significance of lymph node metastasis and multifocality. Cancer 98: 31-40.
28. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2003) Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 28: 1115-1121.
29. Sobin LH and Wittekind CH eds (2002) UICC: TNM classification of malignant tumors, edn 6. New York, NY: Wiley-Liss.
30. Ito Y, Miyauchi A (2007) A therapeutic strategy for incidentally detected papillary microcarcinoma o f the thyroid. Nat Clin Pract Endocrinol Metab 3: 240-248.
31. Ito Y, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2007) Prognosis of patients with benign thyroid diseases accompanied by incidental papillary carcinoma undetectable on preoperative imaging tests. World J Surg 31: 1672-1676.
32. Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma S, Kuma K, Miyauchi A (2003) An observation trial without surgical treatment in patients with papillary micro- carcinoma of the thyroid. Thyroid 13: 381-388.
33. Ito Y, Miyauchi A (2007) Appropriate treatment for asymptomatic papillary microcarcinoma of the thyroid. Expert Opin Pharmacother 8: 3205-3215.
34. Ito Y, Miyauchi A (2005) Therapeutic strategies for papillary micrcarcinoma of the thyroid. Curr Cancer Therapy Review 1: 19-25.
35. Mazzaferri EL, Young RL (1981) Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 97: 418-428.
36. Salvesen H, Njolstad PR, Akslen LA, Albrektsen G, Soreide O, Varhaug JE (1992) Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system. Eur J Surg 158: 583-589.
37. Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H (1994) Prognostic significance and surgical management of locoregional lymph node metastas- es in papillary thyroid cancer. World J Surg 18: 559-567.
38. Bellantone R, Lombardi CP, Boscherini M, Ferrante A, Raffaelli M, Rubino F, Bossola M, Crucitti F (1998) Prognostic factors in differentiated thyroid carcinoma: a multivariate analysis of 234 consecutive patients. J Surg Oncol 68: 237-241.
39. Bottger T, Klupp J, Gabbert HE, Junginger T (1991) Prognostically relevant factors in papillary thyroid cancer. Med Klin 86: 76-82. (in German)
40. Shaha AR, Shah JP, Loree TR (1996) Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol 3: 534-538.
41. Steinmuller T, Klupp J, Rayes N, Ulrich F, Jonas S, Graf KJ, Neuhaus P (2000) Prognostic factors in patients with differentiated thyroid carcinoma. Eur J Surg 166: 29-33.
42. Cady B, Rosai R (1988) An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery 104: 947-953.
43. Hay ID, Grant CS, Taylor WF, MaConahey WM (1987) Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of survical outcome using a novel prognostic scoring system. Surgery 102: 1088-1095.
44. Hay ID, Bergstrahl EJ, Goellner JR, Ebersold JR, Grant CS (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114: 1050-1058.
45. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A (2004) A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow- up period. Surgery 135: 139-148.
46. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 30: 780-786.
47. Ito Y, Miyauchi A, Jikuzono T, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Ichihara K, Kuma K (2007) Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping. World J Surg 31: 838-848.
48. Akslen LA, Myking AO, Salvesen H (1992) Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur J Cancer 29: 44-51.
49. Dralle H, Gimm O (1996) Lymph node excision in thyroid carcinoma. Chirurg 67: 788-806.
50. Ito Y, Tomoda C, Uruno T, Takamura T, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2005) Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 29: 917-920.
51. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2006) Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45 years. Surg Today 36: 12-18.
52. Sakamoto A, Kasai N, Sugano H (1983) Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high risk group of papillary and follicular carcinomas. Cancer 52: 1849-1855.
53. Carcangiu ML, Zampi G, Rosai J (1984) Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans' "Wuchernde Struma." Am J Surg Pathol 8: 655-668.
54. Nishiyama RH (1999) Another dissertation on poorly differentiated carcinomas: is it really necessary? Adv Anat Pathol 6: 281-286.
55. Sobrinho-Simoes M (1996) Poorly differentiated thyroid carcinomas. Endocr Pathol 2: 99-102.
56. Volante M. Landolfi S, Chiusa L, Palestini N, Motta M, Codegone A, TOrchio B, Papotti MG (2004) Poorly differentiated carcinoma of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer 100: 950-957.
57. Aklen LA, LiVolsi VA (2000) Poorly differentiated thyroid carcinoma - it is important. Am J Surg Pathol 24: 310-313.
58. Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda H (1999) Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol 23: 205-211.
59. Sobrinho-Simoes M, Carcangiu ML, Albores-Saavedra J (2004) Poorly differentiated carcinoma. In DeLellis RA, Lloyd RV, Heitz PU et al. editors, Pathology and genetics of tumours of endocrine organs, Lyon, IARC Press, 73-76.
60. Valante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, Lloyd RV, LiVolsi VA, Papotti M, Sobrinho-Simoes M, Bussolati G, Rosai J (2007) Poorly differentiated thyroid carcinoma: The Turin proposal for the use of uniform diagnostic criteria and an algorhthmic diagnostic approach. Am J Surg Pathol 31: 1256-1264.
61. General Rules for the Description of Thyroid Cancer (the 6th edition) (2005) The Japanese Society of Thyroid Surgery, Tokyo, Kanehara Press.
62. Ito Y, Hirokawa M, Fukushima M, Inoue H, Yabuta T, Uruno T, Kihara M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A (2008) Prevalence and prognostic significance of poor differentiation and tall cell variant in papillary carcinoma in Japan. World J Surg 32: 1535-1543.
63. Hawk WA, Hazard JB (1976) The many appearances of papillary carcinoma of the thyroid. Clevel Clin Q 43: 207-215.
64. Michels JJ, Jacques M, Henry-Amar M, Bardet S (2007) Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma. Human Pathol 38: 212-219.
65. Ito Y, Hirokawa M, Uruno T, Uruno T, Kihara M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A (2008) Prevalence and biological behavior of variants of papillary thyroid carcinoma; experience at a single hospital. Pathology 40: 617-622.
66. Chow SM, Chan JK, Law SC, Tang DL, Ho CM, Cheung WY, Wong IS, Lau WH (2003) Diffuse scle-rosing variant of papillary thyroid carcinoma-clinical features and outcome. Eur J Surg Oncol 29: 446-449.
67. Lam AK, Lo CY (2006) Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year compera- tive study at a single institution. Ann Surg Oncol 13: 176-181.
68. Falvo L, Giacomelli L, D'Andrea V, Marzullo A, Guerriero G, de Antoni E (2006) Prognostic importance of sclerosing variant in papillary thyroid carcinoma. Am Surg 75: 438-444.
69. Ito Y, Hirokawa M, Uruno T, Kihara M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyiauchi A (2008) Biological behavior and prognosis of encapsulated papillary carcinoma of the thyroid: Experience of a Japanese hospital for thyroid care. World J Surg 32: 1789-1794.
70. Thyroid Carcinoma Task Force (2001) AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. Endocr Pract 7: 202-220.
71. National Comprehensive Cancer Network (2007) NCCN clinical practice guidelines in oncology. Thyroid carcinoma. Version 2. http://www.nccn.org/ professionals/physician-gls/PDF/thyroid/pdf
72. British Thyroid Association (2007) Guidelines for the management of thyroid cancer. Second ed. http://www. british-thyroid-association.org/Thyroid- cancer-guidelines-2007.pdf
73. The American Thyroid Association Guideline Task- force (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16: 1-33.
74. Sugenoya A, Asanuma K, Shingu K, Omura H, Shimizu T, Masuda H, Kasuga Y, Kobayashi S, Iida F (1993) Clinical evaluation of upper mediastinal dissection for differentiated thyroid carcinoma. Surgery 113: 541-544.
75. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2006) Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 30: 91-99.
76. Dralle H, Gimm O (1996) Lymphadenektomie beim schilddrusencarcinom. Chirurg 67: 788-806. (in German)
77. Martenson H, Terins J (1985) Recurrent laryngeal nerve palsy in thyroid gland surgery related to operations and nerves at risk. Arch Surg 120: 475-482.
78. Scheumann GF, Seeliger H, Musholt TF (1996) Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 162: 677-684.
79. Ito Y, Miyauchi A (2007) Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World J Surg 31: 905-915.
80. McConahey WM, Hay ID, Woolner LB, van Heerden JA, Taylor WF (1986) Papillary thyroid canceer treated at Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 61: 978-996.
81. Wanebo HJ, Andrews W, Kaiser DL (1981) Thyroid cancer: Some basic considerations. Am J Surg 142: 474-479.
82. Cady B. Surgery of thyroid cancer. World J Surg 5: 3-14.
83. Simon D, Goretzki PE, Witte J, Roher HD (1996) Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 20: 860-866.
84. Marchesi M, Biffoni M, Biancan F, Berni A, Campana FP (2002) Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma. Eur J Surg 558: 46-50.
85. Machens A, Hinze R, Thomusch O, Dralle H (2002) Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26: 22-28.
86. Noguchi S, Murakami N, Yamashita H, Tada M, Kawamoto H (1998) Papillary thyroid carcinoma. Modified radical neck dissection improves prognosis. Arch Surg 133: 276-280.
87. Noguchi M, Kumaki T, Kaniya T, Miyazaki I (1990) Bilateral cervical lymph node metastases in well-differentiated thyroid cancer. Arch Surg 125: 804-806.
88. Wada N, Suganuma N, Nakayama H, Masudo K, Rino Y, Masuda M, Imada T (2007) Microscopic regional lymph node status in papillary thyroid carcinoma with and without lymphadenopathy and its relation to outcomes. Langenbecks Arch Surg 392: 417-422.
89. Takamura Y, Miyauchi A, Tomoda C, Uruno T, Ito Y, Miya A, Kobayashi K, Matsuzuka F, Amino N, Kuma K (2005) Stretching exercises to reduce symptoms of postoperative neck discomfort after thyroid surgery: prospective randomized study. World J Surg 29: 775-779.
90. Ito Y, Miiyauchi A (2008) Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma. World J Surg 32: 729-739.
91. Ito Y, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2007) Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preopera- tively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg 31: 2085-2091.
92. Sugitani I, Fujimoto Y, Yamada K, Yamamoto N (2008) Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on properative ultrasonography. World J Surg 32: 2494-2502.
93. Ito Y, Hirokawa M, Fukushima M, Inoue H, Yabuta T, Uruno T, Kihara M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A (2008) Occult papillary thyroid carcinoma: diagnostic and clinical implications in the era of routine ultra- sonography. World J Surg 32: 1955-1960.
94. Mueller-Gaertner HW, Brzac HT, Rehpenning W (1991) Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma. Cancer 67: 1903-1911.
95. Brennan MD, Bergstralh EJ, van Heerden JA, McConahey WM (1991) Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 66: 11-22.
96. Lin JD, Huang HS, Chen SC, Chao TC (1997) Factors that predict metastasis of papillary and follicular thyroid cancers in Taiwan. Otolaryngol Head Neck Surg 116: 475-482.
97. Passler C, Scheuba C, Prager G, Kaczirek K, Kaserer K, Zettinig G, Niederle B (2004) Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocrine- Related Cancer 11: 131-139.
98. Witte J, Goretzki PE, Dieken J, Simon D, Roher HD (2002) Importance of lymph node metastasis in follicu- lar thyroid cancer. World J Surg 26: 1017-1022.
99. Besic N, Zgajnar J, Hocevar M, Frkovic-Grazio S (2005) Is patient's age a prognostic factor for follicular thyroid carcinoma in the TNM classification system? Thyroid 15: 439-448.
100. Chow SM, Law SCK, Mendenhall WM, Au SK, Yau S, Yuen KT, Law CC, Law WH (2002) Follicular thyroid carcinoma. Cancer 95: 488-498.
101. Shaha AR, Loree TR, Shah JP (1995) Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118: 1131-1138.
102. Haigh PI, Urbach DR (2005) The treatment and prognosis of Hurthle cell follicular thyroid carcinioma compared with its non-Hurthle cell counterpart. Surgery 138: 1152-1158.
103. Lang W, Choritz H, Hundeshagen H (1986) Risk factors in follicular thyroid carcinomas. Am J Surg Pathol 10: 246-255.
104. Crile G, Pontius KI, Hawk WA (1985) Factors influencing the survival of patients with follicular carcinoma of the thyroid glands. Surgery, Gynecol & Obstet 160: 409-413.
105. Joensuu H, Klemi PJ, Paul R, Tuominen J (1986) Survival and prognostic factors in thyroid carcinoma. Acta Radiologica Oncology 25: 243-248.
106. Eichhorn W, Tabler H, Lippold R, Lochmann M, Schreckenberger M, Bartenstein P (2003) Prognostic factors determining long-term survival in well-differentiated thyroid cancer: An analysis of four hundred eighty-four patients undergoing therapy and aftercare at the same institution. Thyroid 13: 949-958.
107. Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowics MK, Sutcliffe SB (1998) The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 82: 375-388.
108. Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T (1987) Papillary and follicular thyroid cancer. Am J Med 87: 479-487.
109. Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordoriez NG, Sherman SI (2003) Prognostic factors in patients with Hurthle cell neoplasms of the thyroid. Cancer 97: 1186-1194.
110. Ito Y, Hirokawa M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2007) Prognosis and prognostic factors of follicular carcinoma in Japan: importance of postoperative pathological examination. World J Surg 31: 1672-1676.
111. Williams ED (1990) TSH and thyroid cancer. Horm Metab Res Suppl 138: 10-28.
112. Bakiri F, Djemli FK, Mokrane LA, Djidel FK (1998) The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma. Cancer 82: 1146-1153.
113. Feldt-Rasmussen U (2001) Iodine and cancer. Thyroid 11: 483-486.